Compare, Analyse IPCA Labs with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ACTAVIS (US) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ACTAVIS
EQUITY SHARE DATA
    IPCA LABS
Mar-19
ACTAVIS
Dec-18
IPCA LABS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,04213,911-   
Low Rs5909,331-   
Sales per share (Unadj.) Rs298.63,412.3-  
Earnings per share (Unadj.) Rs35.0-1,099.1-  
Cash flow per share (Unadj.) Rs49.4359.6-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs247.114,074.1-  
Shares outstanding (eoy) m126.35332.60-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.73.4 80.2%   
Avg P/E ratio x23.3-10.6 -220.5%  
P/CF ratio (eoy) x16.532.3 51.1%  
Price / Book Value ratio x3.30.8 399.9%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m103,1083,865,151 2.7%   
No. of employees `00013.416.9 79.5%   
Total wages/salary Rs m7,8740-   
Avg. sales/employee Rs Th2,807.067,155.5 4.2%   
Avg. wages/employee Rs Th585.80-   
Avg. net profit/employee Rs Th329.0-21,630.8 -1.5%   
INCOME DATA
Net Sales Rs m37,7321,134,927 3.3%  
Other income Rs m57721,704 2.7%   
Total revenues Rs m38,3091,156,631 3.3%   
Gross profit Rs m6,90129,741 23.2%  
Depreciation Rs m1,824485,157 0.4%   
Interest Rs m18965,492 0.3%   
Profit before tax Rs m5,465-499,204 -1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0127,317 0.0%   
Tax Rs m1,042-6,326 -16.5%   
Profit after tax Rs m4,422-365,561 -1.2%  
Gross profit margin %18.32.6 697.9%  
Effective tax rate %19.11.3 1,505.2%   
Net profit margin %11.7-32.2 -36.4%  
BALANCE SHEET DATA
Current assets Rs m23,778465,488 5.1%   
Current liabilities Rs m10,975411,786 2.7%   
Net working cap to sales %33.94.7 717.1%  
Current ratio x2.21.1 191.7%  
Inventory Days Days10420 529.8%  
Debtors Days Days6666 99.4%  
Net fixed assets Rs m20,368128,467 15.9%   
Share capital Rs m2530-   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,2244,681,045 0.7%   
Long term debt Rs m1,4091,648,366 0.1%   
Total assets Rs m45,5077,317,539 0.6%  
Interest coverage x30.0-6.6 -452.4%   
Debt to equity ratio x00.4 12.8%  
Sales to assets ratio x0.80.2 534.6%   
Return on assets %10.1-4.1 -247.1%  
Return on equity %14.2-7.8 -181.4%  
Return on capital %17.3-4.8 -357.9%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,923405,467 1.2%  
From Investments Rs m-1,563222,751 -0.7%  
From Financial Activity Rs m-1,832-695,902 0.3%  
Net Cashflow Rs m1,528-67,347 -2.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.89 Rs / USD

Compare IPCA LABS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: STRIDES PHARMA SCIENCE  ABBOTT INDIA  PROCTER & GAMBLE HEALTH  NOVARTIS  SUVEN LIFESCIENCES  



Today's Market

Sensex Ends 82 Points Lower; Energy and Healthcare Stocks Witness Selling(Closing)

Indian share markets witnessed volatile trading activity throughout the day and ended marginally lower.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks (Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

Here's Why I Recommended 15 Stocks in One Day Flat Views On News (Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

The Top 8 Trading Mistakes You Should Avoid (Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

These Rebirth of India Stocks Are Raring to Compete with Tesla (The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

Corona Virus Could Trigger a Rally in this Stock (Profit Hunter)

Feb 20, 2020

A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Guide on How to Profit from Sensex 100,000.
LIVE NOW!: Equitymaster's Biggest Wealth Creating Project Ever is LIVE. Watch Now!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Revealed: Top 7 Stocks to Consider Buying Right Now...

IPCA LABS SHARE PRICE


Feb 25, 2020 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - NATCO PHARMA COMPARISON

COMPARE IPCA LABS WITH

OTHER USEFUL LINKS

MARKET STATS